Aura subvisible particle characterization system for the antivirals for pandemic preparedness project
Ended Purchase Order Awarded
- Contract number
- 75N95021P00491
- Awardee
-
Optofluidics Inc. UEI VDMCGJ1UCJL8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,990
Award facts
- Opportunity
-
- Sub-visible Particle Characterization Instrument for NCATS Pre-Solicitation · 75N95021Q00325 · Posted Jul 22, 2021
- Halo Labs Aura Subvisible Particle Characterization System or Equal (COVID-19 action in support of Antivirals for Pandemic Preparedness) Award Notice · Posted Sep 14, 2021
- Halo Labs Aura Subvisible Particle Characterization System or Equal (COVID-19 action in support of Antivirals for Pandemic Preparedness) Solicitation · Posted Aug 24, 2021
- Contract value 100% obligated
- $149,990.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Hillsborough, CA 94010, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services, National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $149,990.00 firm-fixed price purchase order to Optofluidics, Inc. (doing business as Halo Labs) for an Aura Subvisible Particle Characterization System. This system will be used to support NCATS' Division of Preclinical Innovation research programs and projects, specifically to quantitatively measure and identify sub-visible particles in solutions to determine if compounds of interest are completely dissolved. The award is not set aside and was issued under a small business sources sought notice posted in July 2021, with a response due date of August 6, 2021.
Quick answers
Who was awarded contract 75N95021P00491?
75N95021P00491 was awarded to Optofluidics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 2, 2021.
How much is contract 75N95021P00491 worth?
The government has obligated $149,990 on 75N95021P00491.
Which agency awarded contract 75N95021P00491?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00491, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00491 competed?
The extent of competition for 75N95021P00491 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award